ArticleJournal of clinical medicine2022

Pathological Complete Response Following Neoadjuvant Tislelizumab Monotherapy in Treatment-Naive Locally Advanced, MMR-Deficient/MSI-High Ascending Colon Cancer: A Case Report.

Yue Hei et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.